This clinician-focused webinar is designed for healthcare providers seeking to expand their understanding of compounded hormone replacement therapy (HRT) options for women. Belmar Pharma Solutions Medical Director, Angela DeRosa, DO, MBA, CPE, and Director of Women’s Health, Andi Roths, PharmD, provide a practical overview of compounded dosage forms, prescribing considerations, and customization opportunities that can help support individualized patient care.
Compounded Dosage Forms for Women’s Hormone Therapy
During the presentation, Dr. DeRosa and Andi review the advantages and considerations of numerous compounded dosage forms, including:
- Oral capsules and tablets
- Vaginal cream and suppositories
- Troches
- Nasal sprays
- Hormone pellet therapy
- Injectable therapies
The discussion highlights how different delivery methods may influence:
- Hormone absorption
- Patient adherence
- Dosing flexibility
- Treatment customization
- Clinical outcomes
Clinical Considerations for Hormone Delivery Methods
Dr. DeRosa provides practical insights into selecting appropriate hormone delivery methods for individual patients, including discussions around:
- First-pass metabolism
- Oral vs transdermal hormone therapy
- Progesterone prescribing considerations
- Transmucosal absorption
- Transdermal absorption patterns
- Hormone transfer risks with topical therapies
- Patient-specific treatment selection
The presenters also discuss situations where one dosage form may offer advantages over another based on patient symptoms, preferences, and treatment goals.
Compounded Therapies for Vaginal Health and Sexual Wellness
A significant portion of the webinar focuses on therapies commonly utilized to support vaginal health and sexual wellness.
Topics discussed include:
- Vaginal atrophy
- Vaginal dryness
- Painful intercourse
- Pelvic floor discomfort
- Vulvodynia
- Localized hormone therapy options
The webinar reviews customized formulations containing:
- Estradiol
- Estriol
- Estriol/Estradiol (Bi-Est)
- Progesterone
- Testosterone
- DHEA
- Oxytocin
- Sildenafil
- Bremelanotide (PT-141)
Personalized Compounding Strategies for Women’s Healthcare
Throughout the webinar, Dr. DeRosa and Andi highlight the value of individualized therapies and the role of compounding in supporting personalized patient care.
Key topics covered include:
- Dosage customization
- Combination therapies
- Alternative delivery methods
- Patient-specific formulation strategies
- Treatment adherence considerations
- Clinical decision-making for women’s hormone therapy
The discussion emphasizes how compounding can help clinicians personalize hormone therapies to individual patient needs through customized strengths, dosage forms, and delivery methods while supporting improved adherence and outcomes.
This webinar is intended for providers seeking a broader understanding of women’s HRT compounding options and the clinical considerations associated with personalized hormone therapy.
If you are a provider and would like to watch the webinar, please fill out the form below.
